Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Other hematologic neoplasm 1Lymphoid 1Breast 1

Conditions

Tobacco Use Cessation 1Smoking Cessation 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Patient Participation 1Lung Neoplasms 1Breast Neoplasms 1

Interventions

Cyclophosphamide 910Carboplatin 788pembrolizumab 747Paclitaxel 744Bevacizumab 716Cisplatin 709Gemcitabine 621Docetaxel 584Rituximab 558Radiotherapy 548Dexamethasone 511Nivolumab 491Doxorubicin 445Fluorouracil 392Capecitabine 382Etoposide 358Pemetrexed 339Cytarabine 335Oxaliplatin 335Lenalidomide 328Prednisone 327Erlotinib Hydrochloride 323fludarabine phosphate 316Trastuzumab 305Leucovorin 299fludarabine 296Vincristine 288Bortezomib 284Filgrastim 284Cetuximab 277

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has results × Videotape Recording × Clear all
NCT06138145 2025-04-18

Inclusion Appeal Videos and Intent to Register for Pediatric Clinical Trials

University of Pennsylvania

Phase NA Completed
125 enrolled 9 charts
LymphoidOther hematologic neoplasm

Patient Participation, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05395871 2025-01-30

Behavioural Science Messages in Breast Cancer Screening

Imperial College London

Phase NA Completed
34,047 enrolled 12 charts
Breast

Breast Neoplasms

NCT02286713 2021-02-01

PCORI-CER-1306-03385 Informed Decisions About Lung Cancer Screening

M.D. Anderson Cancer Center

Phase NA Completed
516 enrolled 13 charts
Thoracic

Lung Neoplasms, Smoking Cessation, Tobacco Use Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡